Thomas McLaughlin

2.9k total citations
67 papers, 2.1k citations indexed

About

Thomas McLaughlin is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and General Health Professions. According to data from OpenAlex, Thomas McLaughlin has authored 67 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 17 papers in Cellular and Molecular Neuroscience and 14 papers in General Health Professions. Recurrent topics in Thomas McLaughlin's work include Attention Deficit Hyperactivity Disorder (19 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Child and Adolescent Health (6 papers). Thomas McLaughlin is often cited by papers focused on Attention Deficit Hyperactivity Disorder (19 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Child and Adolescent Health (6 papers). Thomas McLaughlin collaborates with scholars based in United States, Hungary and Israel. Thomas McLaughlin's co-authors include Stephen B. Soumerai, Dennis Ross‐Degnan, Paola Bollini, Jerry Avorn, Daniel F. Connor, Christopher J. Stille, Kenneth Blum, Jerry H. Gurwitz, Richard C. Wasserman and William A. Primack and has published in prestigious journals such as Nature, New England Journal of Medicine and Nucleic Acids Research.

In The Last Decade

Thomas McLaughlin

66 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas McLaughlin United States	24	598	508	398	293	276	67	2.1k
Dag Isacson Sweden	29	356 0.6×	476 0.9×	467 1.2×	148 0.5×	262 0.9×	64	2.3k
David A. Sclar United States	32	383 0.6×	268 0.5×	878 2.2×	403 1.4×	344 1.2×	135	2.9k
Tracy L. Skaer United States	25	277 0.5×	212 0.4×	724 1.8×	305 1.0×	178 0.6×	83	1.9k
Roberta Wines United States	16	160 0.3×	364 0.7×	249 0.6×	591 2.0×	205 0.7×	40	2.5k
Emmanuel Coker‐Schwimmer United States	16	299 0.5×	490 1.0×	279 0.7×	329 1.1×	507 1.8×	30	2.4k
Tami L. Mark United States	35	911 1.5×	1.2k 2.4×	494 1.2×	489 1.7×	238 0.9×	145	4.0k
Yuhua Bao United States	29	432 0.7×	696 1.4×	239 0.6×	267 0.9×	296 1.1×	112	3.1k
Anne M. Libby United States	32	304 0.5×	608 1.2×	501 1.3×	1.1k 3.9×	205 0.7×	96	2.7k
Brent C. Williams United Kingdom	30	163 0.3×	675 1.3×	229 0.6×	114 0.4×	205 0.7×	161	3.2k
Michaël Iskedjian Canada	21	412 0.7×	188 0.4×	439 1.1×	71 0.2×	163 0.6×	66	1.7k

Countries citing papers authored by Thomas McLaughlin

Since Specialization

Citations

This map shows the geographic impact of Thomas McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas McLaughlin more than expected).

Fields of papers citing papers by Thomas McLaughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas McLaughlin. The network helps show where Thomas McLaughlin may publish in the future.

Co-authorship network of co-authors of Thomas McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas McLaughlin. A scholar is included among the top collaborators of Thomas McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas McLaughlin. Thomas McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blum, Kenneth, Thomas McLaughlin, Mark S. Gold, et al.. (2023). Are We Getting High Cause the Thrill is Gone?. PubMed. 7(1). 5–516. 1 indexed citations

Ceccanti, Mauro, Kenneth Blum, Abdalla Bowirrat, et al.. (2022). Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. Journal of Personalized Medicine. 12(12). 2015–2015. 4 indexed citations

Blum, Kenneth, David Han, Abdalla Bowirrat, et al.. (2022). Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index. Journal of Personalized Medicine. 12(11). 1772–1772. 6 indexed citations

Blum, Kenneth, Abdalla Bowirrat, Panayotis K. Thanos, et al.. (2022). Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family. Journal of Personalized Medicine. 12(11). 1864–1864. 6 indexed citations

Blum, Kenneth, Igor Elman, Abdalla Bowirrat, et al.. (2022). Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?. Journal of Personalized Medicine. 12(10). 1719–1719. 10 indexed citations

Blum, Kenneth, Thomas McLaughlin, Abdalla Bowirrat, et al.. (2022). Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”?. Journal of Personalized Medicine. 12(2). 321–321. 23 indexed citations

Blum, Kenneth, Edward J. Modestino, Debasis Bagchi, et al.. (2021). A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. Journal of Personalized Medicine. 11(3). 212–212. 15 indexed citations

Blum, Kenneth, David Baron, Lisa Lott, et al.. (2019). In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing. PubMed. 9(1). 7–21. 20 indexed citations

Blum, Kenneth, Marjorie C. Gondré‐Lewis, Edward J. Modestino, et al.. (2019). Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization. Molecular Neurobiology. 56(11). 7836–7850. 25 indexed citations

10.

McLaughlin, Thomas, Kenneth Blum, Bruce Steinberg, et al.. (2018). Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD. Journal of Behavioral Addictions. 7(1). 192–203. 16 indexed citations

11.

McLaughlin, Thomas, Marlene Oscar‐Berman, Thomas Simpatico, et al.. (2013). Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT). Journal of Behavioral Addictions. 2(2). 117–124. 20 indexed citations

12.

Blum, Kenneth, David K. Han, Marlene Oscar‐Berman, et al.. (2013). Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs. Health. 5(11). 16–34. 1 indexed citations

13.

McLaughlin, Thomas. (2008). Nature and Inertia. The review of metaphysics. 62(2). 251–284.

14.

Connor, Daniel F., et al.. (2007). Randomized Controlled Pilot Study of Quetiapine in the Treatment of Adolescent Conduct Disorder. Journal of Child and Adolescent Psychopharmacology. 18(2). 140–156. 60 indexed citations

15.

Connor, Daniel F. & Thomas McLaughlin. (2005). ANaturalistic Study of Medication Reduction in a Residential Treatment Setting. Journal of Child and Adolescent Psychopharmacology. 15(2). 302–310. 28 indexed citations

16.

Gelfand, Alan E., et al.. (2000). Conditional categorical response models with application to treatment of acute myocardial infarction. Journal of the Royal Statistical Society Series C (Applied Statistics). 49(2). 171–186. 4 indexed citations

17.

Perrin, James M., Karen Kuhlthau, Thomas McLaughlin, Susan L. Ettner, & Steven L. Gortmaker. (1999). Changing Patterns of Conditions Among Children Receiving Supplemental Security Income Disability Benefits. Archives of Pediatrics and Adolescent Medicine. 153(1). 80–4. 49 indexed citations

18.

Soumerai, Stephen B., Thomas McLaughlin, Jerry H. Gurwitz, et al.. (1999). Effect of Local Medical Opinion Leaders on Quality of Care for Acute Myocardial Infarction: A Randomized Controlled Trial. Survey of Anesthesiology. 43(5). 256–257. 36 indexed citations

19.

McLaughlin, Thomas, et al.. (1999). The association between primary source of ambulatory care and access to a outcomes of treatment among AIDS patients. International Journal for Quality in Health Care. 11(4). 293–300. 10 indexed citations

20.

Perrin, James M., et al.. (1998). State variations in supplemental security income enrollment for children and adolescents.. American Journal of Public Health. 88(6). 928–931. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact